Eun-Sol Ha
Overview
Explore the profile of Eun-Sol Ha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ha E, Park H, Jeong J, Lee S, Kang H, Baek I, et al.
Pharmaceutics
. 2025 Jan;
16(12.
PMID: 39771489
This study investigates the impact of supercritical antisolvent (SAS) process parameters on the particle formation of telmisartan, a poorly water-soluble drug. A fractional factorial design was employed to examine the...
2.
Jeong J, Ha E, Park H, Lee S, Kang H, Kim M
Pharmaceuticals (Basel)
. 2024 Nov;
17(11).
PMID: 39598327
Background/objectives: Lifitegrast is an effective treatment for dry eye disease, reducing inflammation and improving the ocular surface condition. Owing to its high sensitivity to oxidation and hydrolysis, formulation studies are...
3.
Lee S, Ha E, Park H, Kang K, Jeong J, Kim J, et al.
Pharmaceutics
. 2023 Dec;
15(12).
PMID: 38140045
In this study, an amorphous solid dispersion containing the poorly water-soluble drug, bisacodyl, was prepared by hot-melt extrusion to enhance its therapeutic efficacy. First, the miscibility and interaction between the...
4.
Yang S, Lee S, Lee Y, Cho J, Kim S, Ha E, et al.
Free Radic Biol Med
. 2023 Aug;
208:194-210.
PMID: 37553025
Nanoplastics (NPs) exposure to humans can occur through various routes, including the food chain, drinking water, skin contact, and respiration. NPs are plastics with a diameter of less than 100 ...
5.
Park H, Ha E, Kim J, Kim M
Bioeng Transl Med
. 2023 May;
8(3):e10485.
PMID: 37206215
This study aimed to develop an improved sustained-release (SR) PLGA microsphere of exenatide using supercritical fluid extraction of emulsions (SFEE). As a translational research, we investigated the effect of various...
6.
Han Won D, Park H, Seo J, Jang S, Ha E, Kim M
Int J Pharm
. 2022 Jun;
623:121927.
PMID: 35716979
This study was aimed to develop a fixed dose combination (FDC) tablet containing a low dose of evogliptin tartrate (6.87 mg) for immediate release combined with a high dose (1000 ...
7.
Kim J, Park H, Ha E, Kang K, Kim M, Hwang S
Pharmaceutics
. 2021 Dec;
13(12).
PMID: 34959341
In this study, supercritical fluid-assisted spray-drying (SA-SD) was applied to achieve the micronization of fenofibrate particles possessing surface-active additives, such as d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), sucrose mono palmitate...
8.
Park H, Kim J, Kim S, Ha E, Kim M, Hwang S
Pharmaceutics
. 2021 Nov;
13(11).
PMID: 34834343
Micro-/nanoparticle formulations containing drugs with or without various biocompatible excipients are widely used in the pharmaceutical field to improve the physicochemical and clinical properties of the final drug product. Among...
9.
Han Won D, Park H, Ha E, Kim H, Jang S, Kim M
Int J Pharm
. 2021 Jul;
605:120838.
PMID: 34197909
A fixed dose combination (FDC) bilayer tablet, consisting of high-dose metformin HCl in a sustained release layer and low-dose evogliptin tartrate in an immediate release layer, was developed based on...
10.
Park H, Ha E, Kim M
Carbohydr Polym
. 2021 May;
266:118169.
PMID: 34044960
The purpose of this study was to evaluate the effects of cyclodextrins (CyDs) to stabilize exnatide in the microencapsulation medium and influence on the pharmaceutical properties of exenatide loaded PLGA...